glp 1 sleep apnea GLP-1 Medications Show Promise as First Drug Therapy for Ozempic and sleep apnea: What
Description
GLP-1 RAs have emerged as promising agents in the treatment of OSA, primarily through their effects on weight reduction and metabolic modulation
Although these drugs have been used to treat type 2 diabetes for nearly two decades, it was not until 2021 that the US FDA approved them for treating obesity
Delayed gastric emptying They decrease gastric motility and prolong the feeling of fullness leading to reduced food intake
Do you have an opinion on the issues raised in this article
doi: 10.1002/DMRR.2810
Likewise, once weekly semaglutide in adolescents caused GI effects in 62% of patients vs
